In Drosophila embryos, the loss of sprouty gene function enhances branching of the respiratory system. Three human sprouty homologues (h-Spry1-3) have been cloned recently, but their function is as yet unknown [1] . Here, we show that a murine sprouty gene (mSpry-2), the product of which shares 97% homology with the respective human protein, is expressed in the embryonic murine lung. We used an antisense oligonucleotide strategy to reduce expression of mSpry-2 by 96%, as measured by competitive reverse transcriptase PCR, in E11.5 murine embryonic lungs cultured for 4 days [2]. Morphologically, the decrease in mSpry-2 expression resulted in a 72% increase in embryonic murine lung branching morphogenesis as well as a significant increase in expression of the lung epithelial marker genes SP-C, SP-B and SP-A. These results support a striking conservation of function between the Drosophila and mammalian sprouty gene families to negatively modulate respiratory organogenesis. 
Results and discussion
The Drosophila respiratory system and the mammalian lung are both formed by a process of branching morphogenesis, which depends on epithelial and mesenchymal interactions mediated by signaling between members of the fibroblast growth factor (FGF) family and their cognate receptors. Branchless, a Drosophila FGF homologue, is expressed in the tips of tracheal branches [3] . Branchless activates an FGF receptor homologue termed Breathless [4] , which directs tracheal cell migration as well as inducing secondary and terminal branches. Sequence homology of mSpry-2 with the Drosophila and human sprouty gene products (h-Spry2 and d-Spry, respectively). Degenerate PCR was used to clone mSpry-2 from E12 mouse lung cDNA resulting in a 948 bp sequence, the product of which has 97% homology to that of the h-Spry2 cDNA sequence. (a) Amino-acid alignment of mSpry-2 with h-Spry2 and d-Spry. The numbering and alignment of amino acids is relative to the cloned sequence of mSpry-2 and begins with the translational start site. Dashes indicate no corresponding amino acid at that position. Shaded residues indicate identical residues. The asterisk indicates amino acids that are missing when mSpry-2 is compared with Drosophila sprouty cDNA sequences. K indicates a lysine residue at position 158 of the murine sequence that is not present in the other sequences. The sprouty gene product functions as an FGF antagonist in Drosophila: overexpression of Sprouty blocks activation of downstream effectors in the Branchless pathway, whereas sprouty null mutation enhances the function of Branchless downstream genes, resulting in enhanced tracheal branching [1] . The Drosophila sprouty gene encodes a 63 kDa polypeptide with a cysteine-rich region that is highly conserved in three human sprouty homologs (h-Spry1-3). The h-Spry2 amino-acid sequence is 51% homologous in the cysteine-rich region to Drosophila Sprouty. We designed degenerate primers to h-Spry2 and used PCR to clone the mSpry-2 sequence from E12 mouse lung cDNA. We found the mSpry-2 amino-acid sequence to be 97% homologous to h-Spry2 ( Figure 1 ).
In Drosophila, sprouty expression is induced near the tracheal epithelium and restricts bud formation by inhibiting the Branchless pathway [1] . We found the expression of mSpry-2 to be highly localized in embryonic lung epithelial cells, primarily in the distal airways (Figure 2a-c) , suggesting that this gene may function as a spatial regulator of new bud formation. Northern analysis showed mSpry-2 to be expressed in the adult lung as well as the heart, brain, skeletal muscle and kidney (Figure 2d ).
Null mutation of the Drosophila sprouty gene results in enhanced tracheal branching [1] , so we designed an antisense oligonucleotide to the translational start site of mSpry-2 ( Figure 1b) to determine its effects on murine lung branching morphogenesis. E11.5 lungs cultured for 4 days in the presence of mSpry-2 antisense oligonucleotide were more extensively branched than control lungs (Figure 3a-d) . In the presence of 40 µM mSpry-2 antisense oligonucleotide, terminal branches increased by 72% compared with lungs grown in control media, 40 µM sense oligonucleotide, or 40 µM scrambled oligonucleotide (Figure 3e ). The proliferating cell nuclear antigen (PCNA) index also increased by 30% in lungs cultured in 40 µM mSpry-2 antisense oligonucleotide (p < 0.01), providing evidence that some stimulation of cell proliferation also occurred following abrogation of endogenous mSpry-2. Competitive PCR methodology [2] showed that the increase in terminal branches was accompanied by a 96% decrease in endogenous mSpry-2 mRNA expression (Figure 4a ), compared with levels in lungs cultured with scrambled and sense oligonucleotide controls (Figure 4b ). We therefore conclude that mSpry-2 antisense oligonucleotide effectively abrogated mSpry-2 mRNA expression. This suggests that in the organization of the mammalian respiratory system, mSpry-2 functions in a similar fashion to sprouty in the respiratory system of Drosophila.
Fetal lung maturation is associated with increased expression of surfactant proteins, which are vital for effective gas exchange at birth [5] . In the developing lung, SP-B and SP-A are expressed in alveolar type 2 (AEC2) cells as well as other epithelial cells in the conducting airways, whereas SP-C is exclusively expressed by AEC2 cells and
Figure 2
Localization of mSpry-2 expression in the mouse lung. In situ hybridization was performed on E12 sectioned lungs as previously described [10] , with minor modifications to embryonic tissue. Northern analysis was performed as previously described [11] . is a specific marker for AEC2 differentiation [6, 7] . SP-C expression can be detected as early as E11, but becomes restricted to the distal portion of the developing lung later in development, whereas SP-A is expressed later in gestation. In this study, these surfactant protein mRNAs were examined as epithelial-specific maturation/differentiation markers. We found that abrogation of mSpry-2 expression resulted in a significant increase in expression of SP-C, SP-A and SP-B mRNAs (Figure 4a,c) , which correlated with increased terminal branching. This suggests that the observed increase in branching is also associated with induction of epithelial maturation.
We suggest that mSpry-2 is a negative regulator of FGF signaling and its apparent function may be to negatively Brief Communication 221 modulate new bud formation. In the developing lung, FGF-10 is highly expressed in the distal mesenchyme and is involved in directing the outgrowth of epithelial buds [8, 9] . FGF-10 expression is downregulated by Sonic hedgehog in the lung endoderm, demonstrating that this specific interaction between the mesenchyme and epithelium is critical in the regulation of lung branching morphogenesis [8] . Also, FGF-10 exerts a chemoattractant effect on embryonic lung epithelia and this effect is similar to that produced by Branchless in the Drosophila tracheal system [9] . We propose that in the developing mouse lung, mSpry-2 negatively modulates bud formation. Further investigation will determine possible interactions between mSpry-2 and FGF signaling.
In conclusion, we report a function for a novel FGF antagonist in mice, encoded by murine Spry-2, which is 97% homologous to the human Spry-2 gene product. The mSpry-2 mRNA is highly abundant in adult mouse lung and brain. In situ hybridization studies on E12 lung sections showed mSpry-2 to be expressed within the distal epithelium. Reducing mSpry-2 expression resulted in increased terminal branching and cell proliferation of murine embryonic lungs in culture as well as increased expression of maturation-specific surfactant-associated protein genes. This evidence supports an evolutionary conservation of function for the sprouty gene family in respiratory organogenesis between Drosophila and mouse.
